Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanna M Rhodes

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
PET Clinics|May 16, 2019
PET/Computed Tomography in Chronic Lymphocytic Leukemia and Richter TransformationJoanna M Rhodes, Anthony R Mato
Cancer Journal (Sudbury, Mass.)|November 26, 2019
Chimeric Antigen Receptor T Cells in Chronic Lymphocytic Leukemia: Are We Any Closer to a Cure?Joanna M Rhodes, Stephen J Schuster
Hematology. American Society of Hematology. Education Program|December 4, 2020
Chemotherapy-free frontline therapy for CLL: is it worth it?Joanna M Rhodes, Jacqueline C Barrientos
Drug Design, Development and Therapy|March 10, 2021
Zanubrutinib (BGB-3111), a Second-Generation Selective Covalent Inhibitor of Bruton's Tyrosine Kinase and Its Utility in Treating Chronic Lymphocytic LeukemiaJoanna M Rhodes, Anthony R Mato
Cancer Journal (Sudbury, Mass.)|May 21, 2026
Older Patients With Hodgkin Lymphoma: A Contemporary ReviewMeghana Subramanian, Andrew Evens, Joanna M Rhodes
Current Oncology Reports|November 5, 2022
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?Joanna M Rhodes, Jacqueline C Barrientos, Kanti R Rai
Hematology. American Society of Hematology. Education Program|December 9, 2023
MRD-directed therapy in CLL: ready for prime time?Joanna M Rhodes, Carlos A Lopez, Jacqueline C Barrientos
Cancer Journal (Sudbury, Mass.)|May 21, 2026
Management of Classic Hodgkin Lymphoma in Special Clinical SituationsThomas Lucido, Robert Ryan, Sara Sawicki, et al.
Leukemia & Lymphoma|October 21, 2022
Vaccination efficacy in patients with chronic lymphocytic leukemiaKevin Y Wang, Pratik Shah, Brandon Skavla, et al.
Pharmacoepidemiology and Drug Safety|August 23, 2023
Combining Super Learner with high-dimensional propensity score to improve confounding adjustment: A real-world application in chronic lymphocytic leukemiaNeil Dhopeshwarkar, Wei Yang, Sean Hennessy, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
PET Clinics|May 16, 2019
PET/Computed Tomography in Chronic Lymphocytic Leukemia and Richter TransformationJoanna M Rhodes, Anthony R Mato
Cancer Journal (Sudbury, Mass.)|November 26, 2019
Chimeric Antigen Receptor T Cells in Chronic Lymphocytic Leukemia: Are We Any Closer to a Cure?Joanna M Rhodes, Stephen J Schuster
Hematology. American Society of Hematology. Education Program|December 4, 2020
Chemotherapy-free frontline therapy for CLL: is it worth it?Joanna M Rhodes, Jacqueline C Barrientos
Drug Design, Development and Therapy|March 10, 2021
Zanubrutinib (BGB-3111), a Second-Generation Selective Covalent Inhibitor of Bruton's Tyrosine Kinase and Its Utility in Treating Chronic Lymphocytic LeukemiaJoanna M Rhodes, Anthony R Mato
Cancer Journal (Sudbury, Mass.)|May 21, 2026
Older Patients With Hodgkin Lymphoma: A Contemporary ReviewMeghana Subramanian, Andrew Evens, Joanna M Rhodes
Current Oncology Reports|November 5, 2022
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?Joanna M Rhodes, Jacqueline C Barrientos, Kanti R Rai
Hematology. American Society of Hematology. Education Program|December 9, 2023
MRD-directed therapy in CLL: ready for prime time?Joanna M Rhodes, Carlos A Lopez, Jacqueline C Barrientos
Cancer Journal (Sudbury, Mass.)|May 21, 2026
Management of Classic Hodgkin Lymphoma in Special Clinical SituationsThomas Lucido, Robert Ryan, Sara Sawicki, et al.
Leukemia & Lymphoma|October 21, 2022
Vaccination efficacy in patients with chronic lymphocytic leukemiaKevin Y Wang, Pratik Shah, Brandon Skavla, et al.
Pharmacoepidemiology and Drug Safety|August 23, 2023
Combining Super Learner with high-dimensional propensity score to improve confounding adjustment: A real-world application in chronic lymphocytic leukemiaNeil Dhopeshwarkar, Wei Yang, Sean Hennessy, et al.
Pageof 3